Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

VIP-236 demonstrates potent antitumor efficacy in xenograft models

May 10, 2021

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

May 10, 2021

Bayer, Deutsches Krebsforschungszentrum present new MAP4K1 inhibitors

May 10, 2021

PTPN11 inhibitors discovered at Hangzhou Rex Pharmaceutical

May 10, 2021

Lead Pharma Holding presents new ERR-alpha inverse agonists

May 10, 2021

PEP-010 enters first-in-human study in solid tumors

May 10, 2021

PLEK2 as prognostic biomarker and therapeutic target in ESCC

May 7, 2021

China NMPA grants conditional approval to pamiparib for advanced ovarian cancer

May 7, 2021

Phase II trial shows improved PFS when relacorilant is added to nab-paclitaxel in ovarian cancer

May 7, 2021

Betta Pharmaceuticals synthesizes EGFR inhibitors

May 7, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...